In vivo , E2 treatment also activated estrogen signaling in inflammatory cells at the wound site during skin wound healing, a process that was inhibited in estrogen-deprived skin and restored upon estrogen application (Emmerson et al., 2013
Currently, there are a total of ten FDA-approved indications for hGH therapy [5]: Growth hormone deficiency in children and adults (GHD) Growth failure due to chronic renal insufficiency Muscle wasting due to AIDS Noonan syndrome Prader-Willi syndrome Short bowel syndrome (SBS) Short stature homeobox (SHOX)-containing gene deficiency Small-for-gestational-age infants Turner syndrome Recombinant hGH therapy can effectively and dose-dependently increase serum GH levels, hence its use in managing the symptoms of GHD in children and adults
Secondary outcomes generated similar results but with wider confidence intervals
This period is expected to be characterized by expansion of public reimbursement programs in major European and Asian markets, maturation of cardiovascular-anchored treatment protocols, and broader adoption across middle-income countries
First described as juvenile melanoma by Sophie Spitz in 1948 [23], it is now established that Spitz tumors fall in a spectrum from benign to malignant, with many tumors previously included in the original series of juvenile melanoma reclassified as Spitz nevi
doi: 10.1210/clinem/dgaf278 181 MartinCKCarmichaelOTCarnellSConsidineRVKarekenDADydakUet al